Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ollila

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J Olszewski
Blood Advances|July 17, 2023
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysisThomas A Ollila, Rashida Taher, Prashanth Moku, et al.
The Oncologist|April 21, 2020
Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown PrimaryBrianna R Bakow, Christopher P Elco, Mark LeGolvan, et al.
British Journal of Haematology|September 22, 2025
Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphomaAdam J Olszewski, Diana O Treaba, Allison Winter, et al.
The Lancet. Haematology|April 2, 2025
Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic reviewCharles J Milrod, Lila Rubin, Boris Martinez, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|October 15, 2016
Perioperative Myocardial Infarction in Non-Cardiac Surgery Patients: A Prospective Observational StudyA Ollila, L Vikatmaa, J Virolainen, et al.
British Journal of Haematology|April 4, 2024
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysisCharles J Milrod, Kang Woo Kim, Christina Raker, et al.
American Journal of Hematology|September 24, 2022
Drug-induced hypersensitivity syndrome and eosinophils in skin biopsy in a patient with pancytopeniaBenjamin Gallo Marin, Thomas A Ollila, Allison Robbins, et al.
JAMA Oncology|August 11, 2021
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant DiseaseThomas A Ollila, Shaolei Lu, Rebecca Masel, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J Olszewski
Blood Advances|July 17, 2023
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysisThomas A Ollila, Rashida Taher, Prashanth Moku, et al.
The Oncologist|April 21, 2020
Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown PrimaryBrianna R Bakow, Christopher P Elco, Mark LeGolvan, et al.
British Journal of Haematology|September 22, 2025
Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphomaAdam J Olszewski, Diana O Treaba, Allison Winter, et al.
The Lancet. Haematology|April 2, 2025
Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic reviewCharles J Milrod, Lila Rubin, Boris Martinez, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|October 15, 2016
Perioperative Myocardial Infarction in Non-Cardiac Surgery Patients: A Prospective Observational StudyA Ollila, L Vikatmaa, J Virolainen, et al.
British Journal of Haematology|April 4, 2024
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysisCharles J Milrod, Kang Woo Kim, Christina Raker, et al.
American Journal of Hematology|September 24, 2022
Drug-induced hypersensitivity syndrome and eosinophils in skin biopsy in a patient with pancytopeniaBenjamin Gallo Marin, Thomas A Ollila, Allison Robbins, et al.
JAMA Oncology|August 11, 2021
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant DiseaseThomas A Ollila, Shaolei Lu, Rebecca Masel, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.
Pageof 5